nmm 22 4500 ICPSR03404 MiAaI m f a u cr mn mmmmuuuu 130521s2004 miu f a eng d (MiAaI)ICPSR03404 MiAaI MiAaI Drug Abuse Treatment Outcome Study--Adolescent (DATOS-A), 1993-1995 [electronic resource] [United States] United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-10-07 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2004 ICPSR 3404 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. Drug Abuse Treatment Outcome Study - Adolescent (DATOS-A) was a multisite, prospective, community-based, longitudinal study of adolescents entering treatment. It was designed to evaluate the effectiveness of adolescent drug treatment by investigating the characteristics of the adolescent population, the structure and process of drug abuse treatment in adolescent programs, and the relationship of these factors with outcomes. Three major types or modalities of programs included in the study were chemical dependency or short-term inpatient (STI), therapeutic community or residential (RES), and outpatient drug-free (ODF). The adolescent battery of instruments included intake, intreatment, and follow-up questionnaires based largely on the DATOS adult study DRUG ABUSE TREATMENT OUTCOME STUDY (DATOS), 1991-1994: [UNITED STATES] (ICPSR 2258) instrument format, with considerable tailoring to the adolescent population. Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, such as illegal involvement, as well as information on background and demographic characteristics, education and training, mental health status, employment, income and expenditures, drug and alcohol dependence, health, religiosity and self-concept, and motivation and readiness for treatment. The one-, three-, and six-month intreatment interviews (Parts 3, 4, and 7) included items on treatment access, intreatment experience, and psychological functioning, as well as questions replicated from some of the domains in the Intake 1 and 2 questionnaires. The 12-month post-treatment follow-up interview (Part 5) included questions replicated from the previous interviews, and also included post-treatment status. Part 6 includes variables for time in treatment and interview availability indicators. The Measures Data (Part 8) were generated by using the Diagnostic and Statistical Manual of Mental Disorders (Rev. 3rd ed., DSM-III-R) (American Psychiatric Association, 1987). The variables in Part 8 give either the DSM-III-R level of dependence to a drug category or they describe whether the subject meets the DSM-III-R standard for a particular disorder. The 12-Month Follow-up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-up Interview. The urine test was used to ascertain the nature and extent of bias in the self-reports of the respondents. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, illegal methadone, sedatives and tranquilizers such as barbiturates and depressants, amphetamines or other stimulants such as speed or diet pills, methamphetamines, LSD, PCP, and other hallucinogens or psychedelics, and inhalants such as glue, gasoline, paint thinner, and aerosol sprays. The study also included drug of choice, frequency, and route of administration. Cf.: http://dx.doi.org/10.3886/ICPSR03404.v3 adolescents icpsr AIDS icpsr alcohol abuse icpsr drug abuse icpsr drug treatment icpsr drug use icpsr education icpsr employment icpsr health icpsr HIV icpsr mental health icpsr sexual behavior icpsr substance abuse treatment icpsr tobacco use icpsr treatment outcome icpsr treatment programs icpsr ICPSR XVI.A. Social Indicators, United States SAMHDA XXII. Drug Abuse Treatment Outcome Study - Adolescent (DATOS-A) NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 3404 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR03404.v3